Management and outcomesof Burkholderia cepaciacomplex bacteremia in patients without cystic fibrosis: a retrospective observational study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yu-Mi | - |
dc.contributor.author | Park, Ki-Ho | - |
dc.contributor.author | Moon, Chisook | - |
dc.contributor.author | Kim, Dong Youn | - |
dc.contributor.author | Lee, Mi Suk | - |
dc.contributor.author | Kim, Tark | - |
dc.contributor.author | Choo, Eun Ju | - |
dc.contributor.author | Chong, Yong Pil | - |
dc.contributor.author | Kim, Sung-Han | - |
dc.contributor.author | Kim, Yang Soo | - |
dc.contributor.author | Woo, Jun Hee | - |
dc.contributor.author | Chang, Mee Soo | - |
dc.date.accessioned | 2021-08-11T08:32:28Z | - |
dc.date.available | 2021-08-11T08:32:28Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 0934-9723 | - |
dc.identifier.issn | 1435-4373 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2384 | - |
dc.description.abstract | Burkholderia cepaciacomplex (BCC) is an emerging pathogen of nosocomial infection in chronic or critically ill patients without cystic fibrosis (CF). The objective was to evaluate the management and outcomes of BCC bacteremia in patients without CF. We conducted a retrospective study of non-CF adult patients with BCC bacteremia between January 1997 and December 2016 at 4 tertiary hospitals in South Korea. A total of 216 non-CF patients with BCC bacteremia were identified. Most cases were hospital-acquired (79.2%), and the most common source was a central venous catheter (CVC) (42.1%). The rates of susceptibility to trimethoprim-sulfamethoxazole and piperacillin-tazobactam of BCC isolates were high as 92.8% and 90.3%, respectively. The rates of susceptibility to ceftazidime, meropenem, and levofloxacin were 75.5%, 72.3%, and 64.1%, respectively. The 14-day, 30-day, and in-hospital mortality rate was 19.4%, 23.1%, and 31.0%, respectively. Female (OR = 3.1; 95% CI, 1.4-6.8), liver cirrhosis (OR = 6.2; 95% CI, 1.6-16.6), septic shock (OR = 11.2; 95% CI, 5.1-24.8), and catheter-related infection (OR = 2.6, 95% CI, 1.2-5.8) were the independent risk factors for 30-day mortality. The outcome did not differ according to type of antibiotics used. Among 91 patients with CVC-related BCC bacteremia, delayed CVC removal (> 3 days) had a higher rate of persistent bacteremia (54.5 vs. 26.1%;P = 0.03) and lower rate of clinical response (49.0 vs. 71.9%;P = 0.04), compared with early CVC removal (within 3 days). BCC bacteremia occurring in non-CF patients was mostly hospital-acquired and CVC-related. Early removal of the catheter is crucial in treatment of CVC-related BCC bacteremia. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | Management and outcomesof Burkholderia cepaciacomplex bacteremia in patients without cystic fibrosis: a retrospective observational study | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s10096-020-03960-2 | - |
dc.identifier.scopusid | 2-s2.0-85087058182 | - |
dc.identifier.wosid | 000543015300001 | - |
dc.identifier.bibliographicCitation | European Journal of Clinical Microbiology and Infectious Diseases, v.39, no.11, pp 2057 - 2064 | - |
dc.citation.title | European Journal of Clinical Microbiology and Infectious Diseases | - |
dc.citation.volume | 39 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 2057 | - |
dc.citation.endPage | 2064 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTIONS | - |
dc.subject.keywordPlus | STENOTROPHOMONAS-MALTOPHILIA | - |
dc.subject.keywordPlus | CLINICAL CHARACTERISTICS | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | CATHETER | - |
dc.subject.keywordPlus | OUTBREAK | - |
dc.subject.keywordPlus | UPDATE | - |
dc.subject.keywordAuthor | Bacteremia | - |
dc.subject.keywordAuthor | Burkholderia cepaciacomplex | - |
dc.subject.keywordAuthor | Central venous catheter | - |
dc.subject.keywordAuthor | Outcome | - |
dc.subject.keywordAuthor | Risk factor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.